Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

被引：1
作者：
Kow, Chia Siang [1 ]
Hasan, Syed Shahzad [2 ,3 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2021年 / 19卷 / 01期
关键词：
ANTIHYPERTENSIVE DRUGS; OUTCOME INCIDENCE; RISK; ANGIOEDEMA;
D O I：
10.1080/14779072.2021.1842050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [21] Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
    Mamdani, Muhammad
    Gomes, Tara
    Greaves, Simon
    Manji, Selina
    Juurlink, David N.
    Tadrous, Mina
    Kennedy, Sidney H.
    Antoniou, Tony
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [22] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
    Xiao, Lin
    Ouyang, Haichun
    Su, Qiwen
    Huang, Yuli
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 56 - 57
  • [23] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [24] Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [25] Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?
    Mao, Yeqing
    Xu, Xin
    Wang, Xiao
    Zheng, Xiangyi
    Xie, Liping
    ONCOTARGET, 2016, 7 (06) : 6765 - 6773
  • [26] Latrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers
    Roskiewicz, France
    Andriamanana, Irina
    Gras-Champel, Valerie
    Andrejak, Michel
    Massy, Ziad A.
    NEPHROLOGIE & THERAPEUTIQUE, 2007, 3 (03): : 89 - 95
  • [27] COVID-19, Angiotensin Receptor Blockers, and the Brain
    Saavedra, Juan M.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2020, 40 (05) : 667 - 674
  • [28] Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer
    Helgeson, Scott A.
    Waddle, Mark R.
    Burnside, Rebecca C.
    Debella, Yalew T.
    Lee, Augustine S.
    Burger, Charles D.
    Li, Zhuo
    Johnson, Patrick W.
    Patel, Neal M.
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (09) : 607 - 613
  • [29] Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
    Dambha-Miller, Hajira
    Hinton, William
    Wilcox, Christopher R.
    Lemanska, Agnieszka
    Joy, Mark
    Feher, Michael
    Stuart, Beth
    de Lusignan, Simon
    Hippisley-Cox, Julia
    Griffin, Simon
    FAMILY PRACTICE, 2023, 40 (02) : 330 - 337
  • [30] Role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers
    Gulec, M.
    Caliskaner, Z.
    Tunca, Y.
    Ozturk, S.
    Bozoglu, E.
    Gul, D.
    Erel, F.
    Kartal, O.
    Karaayvaz, M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2008, 36 (03) : 134 - 140
12345